trial · primary record
Cabozantinib
Castration-resistant Prostate Cancer
| Phase | Phase 2 |
|---|---|
| Status | ACTIVE |
| Sponsor | Unknown |
| Enrolment | 47 |
| Primary completion | 2027-11-12 |
| Primary endpoint | Radiographic Progression Free Survival (rPFS) |
| Registry ID | NCT05502315 |
Provenance
- Source: ClinicalTrials.gov
- Fetched at: 2026-11-02T15:47:08.521Z
- Licence class: attribution-required
- Verdict: primary-source
- Entity id: NCT05502315
This record is rendered from the AEaH spine. If the source is unreachable the page is not generated.
Same entity, elsewhere in the suite
- Cabozantinib · approval
- Cabozantinib · compound